Events

AIDS 2026 pre-conference: 12th Symposium on Children and Adolescents with Perinatal HIV Exposure

As of 2024, an estimated 16 million children under 15 years of age had been perinatally exposed to HIV globally and were born HIV-free. An expanding body of evidence shows that these children experience a higher likelihood of infectious morbidity, mortality, impaired growth and suboptimal neurodevelopmental and cognitive outcomes than peers born to mothers without HIV, with the aetiology of these adverse outcomes reflecting an interplay of biological, social and structural factors.

AIDS 2026 HIV cure pre-conference, "HIV cure without borders: Science, community and Latin America and Caribbean perspectives"

AIDS 2026 pre-conference, "Advancing HIV prevention science and access"

To accelerate progress in HIV prevention, it is increasingly important to translate emerging scientific innovations into real-world impact. Recent breakthroughs, including the approval of lenacapavir, the first twice-yearly injectable PrEP, alongside advances in broadly neutralizing antibodies, mRNA-based platforms and immunogen design, are expanding the range of prevention options. However, these advances will have impact only if they are affordable, accessible and delivered at scale, particularly in low- and middle-income settings and for people most affected by HIV.

The 26th International AIDS Conference

AIDS 2026, the 26th International AIDS Conference, taking place in Rio de Janeiro, Brazil, and virtually on 26-31 July 2026.

HIV vaccine 101: A primer for early-career researchers ahead of AIDS 2026

Advocacy in HIV care: From practice to impact